KRAS and colonic neoplasm: For 29 stage II and 31 stage III colon cancer samples, mutation analysis of APC, TP53, KRAS, PIK3CA, FBXW7, SMAD4, BRAF and NRAS passed quality control (Supplementary Table S3).